Henry Schein Q2 Earnings Miss Estimates, Revenue Grows 3.3%
PorAinvest
martes, 5 de agosto de 2025, 12:57 pm ET1 min de lectura
HSIC--
Total net sales for the quarter reached $3.2 billion, a 3.3% increase from the prior-year period. This growth was driven by a 1.9% internal sales growth, a 0.8% sales growth from acquisitions, and a 0.6% increase due to foreign currency exchange [1].
However, profitability and margins fell due to softening U.S. dental sales. Global Dental Distribution merchandise sales increased by 0.3%, but decreased 0.4% in constant currencies compared to the same period last year. U.S. volume increased at lower average selling prices, partly due to lower glove pricing and time-limited targeted sales initiatives [1].
The company's Specialty Products and Technology Groups continued to deliver strong results, driven primarily by sales from innovative products and solutions, and cost efficiencies [1]. Global Technology sales increased by 7.4%, with practice management systems like Dentrix Ascend and Dentally cloud-based solutions contributing significantly to this growth [1].
Henry Schein's focus on expanding specialty products, technology solutions, and value-added services, as well as strategic acquisitions and partnerships, remains key to its success. The company is maintaining its guidance for 2025, expecting non-GAAP diluted EPS to be $4.80 to $4.94, reflecting growth of 1% to 4% over 2024 [1].
The company also reported that it repurchased approximately 3.7 million shares of common stock at an average price of $70.88 per share for a total of $259 million during the second quarter of 2025 [1].
References:
[1] https://investor.henryschein.com/news-releases/news-release-details/henry-schein-reports-second-quarter-2025-financial-results
Henry Schein's Q2 EPS dropped 11% to $1.10, missing analyst expectations by 7.6%. Revenue reached $3.24 billion, increasing 3.3% compared to the prior-year period. Profitability and margins fell due to softening U.S. dental sales and declining GAAP and non-GAAP net income and Adjusted EBITDA compared to the prior-year period. The company's focus on expanding specialty products, technology solutions, and value-added services, as well as strategic acquisitions and partnerships, remains key to its success.
Henry Schein, Inc. (Nasdaq: HSIC) reported its second-quarter 2025 financial results, showing mixed performance with a notable drop in earnings per share (EPS) and a slight increase in revenue. The company's quarterly GAAP diluted EPS fell to $0.70, a 11% decline compared to the same period in 2024, which was $0.80 per share [1]. Non-GAAP diluted EPS dropped to $1.10, down 11% from $1.23 in the second quarter of 2024 [1].Total net sales for the quarter reached $3.2 billion, a 3.3% increase from the prior-year period. This growth was driven by a 1.9% internal sales growth, a 0.8% sales growth from acquisitions, and a 0.6% increase due to foreign currency exchange [1].
However, profitability and margins fell due to softening U.S. dental sales. Global Dental Distribution merchandise sales increased by 0.3%, but decreased 0.4% in constant currencies compared to the same period last year. U.S. volume increased at lower average selling prices, partly due to lower glove pricing and time-limited targeted sales initiatives [1].
The company's Specialty Products and Technology Groups continued to deliver strong results, driven primarily by sales from innovative products and solutions, and cost efficiencies [1]. Global Technology sales increased by 7.4%, with practice management systems like Dentrix Ascend and Dentally cloud-based solutions contributing significantly to this growth [1].
Henry Schein's focus on expanding specialty products, technology solutions, and value-added services, as well as strategic acquisitions and partnerships, remains key to its success. The company is maintaining its guidance for 2025, expecting non-GAAP diluted EPS to be $4.80 to $4.94, reflecting growth of 1% to 4% over 2024 [1].
The company also reported that it repurchased approximately 3.7 million shares of common stock at an average price of $70.88 per share for a total of $259 million during the second quarter of 2025 [1].
References:
[1] https://investor.henryschein.com/news-releases/news-release-details/henry-schein-reports-second-quarter-2025-financial-results

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios